Fig. 4From: Development of a Platform of Antibody-Presenting LiposomesDispersity of liposome suspensions, by DLS. Size distribution profiles determined by DLS at 90° for a (DOPC:DOPS) liposomes (70:30, mole ratio); b liposomes obtained after sequential binding of Anx5ZZ (60 Anx5ZZ/liposome, 6% of surface coverage), and then IgGs (120 IgGs/liposome); c liposomes obtained after binding of pre-formed Anx5ZZ–IgG complexes (60 Anx5ZZ–120IgG per liposome)Back to article page